Laurel Wealth Advisors (North Carolina)’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $34.5K | Buy |
|
|||||
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $27.6K | Hold |
|
|||||
|
2024
Q4 | $24.6K | Sell |
|
|||||
|
2024
Q3 | $32.7K | Buy |
|
|||||
|
2024
Q2 | $29.2K | Hold |
|
|||||
|
2024
Q1 | $25.4K | Hold |
|
|||||
|
2023
Q4 | $25.3K | Hold |
|
|||||
|
2023
Q3 | $25.4K | Hold |
|
|||||
|
2023
Q2 | $26.8K | Sell |
|
|||||
|
2023
Q1 | $52.1K | Buy |
|
|||||
|
2022
Q4 | $25.4K | Hold |
|
|||||
|
2022
Q3 | $21K | Hold |
|
|||||
|
2022
Q2 | $25K | Hold |
|
|||||
|
2022
Q1 | $25K | Hold |
|
|||||
|
2021
Q4 | $22K | Hold |
|
|||||
|
2021
Q3 | $23K | Hold |
|
|||||
|
2021
Q2 | $22K | Hold |
|
|||||
|
2021
Q1 | $19K | Hold |
|
|||||
|
2020
Q4 | $19K | Hold |
|
|||||
|
2020
Q3 | $21K | Hold |
|
|||||
|
2020
Q2 | $20K | Buy |
|